These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8486458)

  • 21. The treatment of vitiligo with topical corticosteroids. Light and electronmicroscopic studies.
    Bleehen SS
    Br J Dermatol; 1976 Mar; 94 suppl 12():43-50. PubMed ID: 773413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probable mechanisms of loss of Merkel cells in completely depigmented skin of stable vitiligo.
    Bose SK
    J Dermatol; 1994 Oct; 21(10):725-8. PubMed ID: 7798428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repigmentation in vitiligo universalis: role of melanocyte density, disease duration, and melanocytic reservoir.
    Dogra S; Kumar B
    Dermatol Online J; 2005 Dec; 11(3):30. PubMed ID: 16409926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermal reconstructs in vitiligo: an extrinsic factor is needed to trigger the disease.
    Bessou S; Gauthier Y; Surlève-Bazeille JE; Pain C; Taïeb A
    Br J Dermatol; 1997 Dec; 137(6):890-7. PubMed ID: 9470904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and histopathologic characteristics of trichrome vitiligo.
    Hann SK; Kim YS; Yoo JH; Chun YS
    J Am Acad Dermatol; 2000 Apr; 42(4):589-96. PubMed ID: 10727303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ultrastructural studies in vitiligo].
    Koshevenko IuN; Mikhaĭlov IN; Semkin VI
    Vestn Dermatol Venerol; 1983 Feb; (2):21-4. PubMed ID: 6845868
    [No Abstract]   [Full Text] [Related]  

  • 27. Repigmentation of vitiligo macules treated topically with Efudix cream.
    Szekeres E; Morvay M
    Dermatologica; 1985; 171(1):55-9. PubMed ID: 4029463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Keratinocyte damage in vitiligo.
    Bhawan J; Bhutani LK
    J Cutan Pathol; 1983 Jun; 10(3):207-12. PubMed ID: 6190850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in the melanosome distribution within the epidermal melanin units and its association with the impairing background of leukoderma in vitiligo and halo nevi: a retrospective study.
    Xiong XX; Ding GZ; Zhao WE; Li X; Ling YT; Sun L; Gong QL; Lu Y
    Arch Dermatol Res; 2017 Jul; 309(5):323-333. PubMed ID: 28314912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nevus depigmentosus: clinical features and histopathologic characteristics in 67 patients.
    Lee HS; Chun YS; Hann SK
    J Am Acad Dermatol; 1999 Jan; 40(1):21-6. PubMed ID: 9922008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The early repigmentation pattern of vitiligo is related to the source of melanocytes and by the choice of therapy: a retrospective cohort study.
    Yang K; Xiong X; Pallavi G; Ling Y; Ding F; Duan W; Sun W; Ding G; Gong Q; Zhu W; Lu Y
    Int J Dermatol; 2018 Mar; 57(3):324-331. PubMed ID: 29318595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Repigmentation of vitiligo induced by oral photochemotherapy. Histoenzymological and ultrastructural study (author's transl)].
    Ortonne JP; MacDonald DM; Micoud A; Thivolet J
    Ann Dermatol Venereol; 1978 Nov; 105(11):939-40. PubMed ID: 754609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pentachrome vitiligo.
    Fargnoli MC; Bolognia JL
    J Am Acad Dermatol; 1995 Nov; 33(5 Pt 2):853-6. PubMed ID: 7593796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunolocalization of tenascin-C in vitiligo.
    Abdou AG; Maraee AH; Shoeib MA; Elbana R
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):501-11. PubMed ID: 22495383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical analysis of melanocyte content in different zones of vitiligo lesions using the Melan-A marker.
    Kubanov A; Proshutinskaia D; Volnukhin V; Katunina O; Abramova T
    Acta Dermatovenerol Alp Pannonica Adriat; 2016; 25(1):5-9. PubMed ID: 27014772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo.
    Lee AY; Kim NH; Choi WI; Youm YH
    J Invest Dermatol; 2005 May; 124(5):976-83. PubMed ID: 15854039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of melanoblasts and melanocytes after treatment with monochromatic excimer light and narrowband-ultraviolet B of skin of vitiligo patients.
    Hirobe T; Enami H
    Int J Dermatol; 2019 Feb; 58(2):210-217. PubMed ID: 30191560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrastructural studies of vitiligo with inflammatory raised borders.
    Ishii M; Hamada T
    J Dermatol; 1981 Aug; 8(4):313-22. PubMed ID: 7028831
    [No Abstract]   [Full Text] [Related]  

  • 39. Repigmentation of vitiliginous skin by cultured cells.
    Brysk MM; Newton RC; Rajaraman S; Plott T; Barlow E; Bell T; Penn P; Smith EB
    Pigment Cell Res; 1989; 2(3):202-7. PubMed ID: 2475866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathologic features in vitiligo.
    Kim YC; Kim YJ; Kang HY; Sohn S; Lee ES
    Am J Dermatopathol; 2008 Apr; 30(2):112-6. PubMed ID: 18360112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.